Improved efficacy of mitoxantrone in patients with castration-resistant prostate cancer after vaccination with GM-CSF-transduced allogeneic prostate cancer cells.

van Dodewaard-de Jong, Joyce M; Santegoets, Saskia Jam; van de Ven, Peter M; Versluis, Jurjen; Verheul, Henk M W; de Gruijl, Tanja D; Gerritsen, Winald R; van den Eertwegh, Alfons J M

van Dodewaard-de Jong, Joyce M; Santegoets, Saskia Jam; van de Ven, Peter M; Versluis, Jurjen; Verheul, Henk M W; de Gruijl, Tanja D; Gerritsen, Winald R; van den Eertwegh, Alfons J M.

Affiliation

van Dodewaard-de Jong JM; Department of Medical Oncology, VU University Medical Center , Amsterdam, the Netherlands.
Santegoets SJ; Department of Clinical Oncology, Leiden University Medical Center , Leiden, the Netherlands.
van de Ven PM; Department of Epidemiology and Biostatistics, VU University Medical Center , Amsterdam, the Netherlands.
Versluis J; Department of Medical Oncology, VU University Medical Center , Amsterdam, the Netherlands.
Verheul HM; Department of Medical Oncology, VU University Medical Center , Amsterdam, the Netherlands.
de Gruijl TD; Department of Medical Oncology, VU University Medical Center , Amsterdam, the Netherlands.
Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center , Nijmegen, the Netherlands.
van den Eertwegh AJ; Department of Medical Oncology, VU University Medical Center , Amsterdam, the Netherlands.

Oncoimmunology ; 5(4): e1105431, 2016 Apr.

Article in En | MEDLINE | ID: mdl-27141390

Key words

Cancer vaccines; GVAX; chemotherapy; docetaxel; immunotherapy; mitoxantrone; prostate cancer

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Language: En Journal: Oncoimmunology Year: 2016 Document type: Article Affiliation country: Netherlands Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google